BioLineRX Ltd (BLRX) is a publicly traded Healthcare sector company. As of May 19, 2026, BLRX trades at $2.74 with a market cap of $12.97M and a P/E ratio of 0.00. BLRX moved +0.00% today. Year to date, BLRX is -0.18%; over the trailing twelve months it is -13.73%. Its 52-week range spans $2.15 to $26.80. Analyst consensus is buy with an average price target of $12.00. Rallies surfaces BLRX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Hedge funds tracked by Rallies that own BLRX include Highbridge Capital. The latest tracked quarter is Dec 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for BioLineRX Ltd.
| Metric | Value |
|---|---|
| Price | $2.74 |
| Market Cap | $12.97M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $26.80 |
| 52-Week Low | $2.15 |
| Volume | 1.21M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
1 analysts cover BLRX: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $12.00.